
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Apollon Formularies plc | AQSE:APOL | Aquis Stock Exchange | Ordinary Share | IM00BJ0LRD77 |
Price Change | % Change | Share Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|
0.00 | 0.0% | 0.15 | 960,000 | 15:29:56 |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
0.10 | 0.20 | 0.15 | 0.10 | 0.15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
- |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
16:12:23 | 960,000 | 0.10 | GBX |
Date | Time | Source | Headline |
---|---|---|---|
05/12/2023 | 11:59 | UKREG | Apollon Formularies Plc Notice of AGM |
21/11/2023 | 20:52 | ALNC | ![]() |
21/11/2023 | 11:51 | UKREG | Apollon Formularies Plc Sproutly and Apollon Conclude Due Diligence, Paving.. |
03/10/2023 | 10:01 | ALNC | ![]() |
29/9/2023 | 06:00 | UKREG | Apollon Formularies Plc Interim Results for the 6 Months ended 30 June 2023 |
19/9/2023 | 08:18 | UKREG | Apollon Formularies Plc Execution of Binding LOI with Sproutly Canada, Inc. |
03/8/2023 | 09:51 | UKREG | Apollon Formularies Plc Resignation of Non-Executive Director |
02/8/2023 | 11:19 | UKREG | Apollon Formularies Plc Update on Global Hemp Group |
24/7/2023 | 20:08 | ALNC | ![]() |
24/7/2023 | 10:00 | UKREG | Apollon Formularies Plc Apollon grants an Exclusive Licence Agreement to.. |
Apollon Formularies (APOL) Share Charts1 Year Apollon Formularies Chart |
|
1 Month Apollon Formularies Chart |
Intraday Apollon Formularies Chart |
Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
---|---|---|---|---|
2023-12-07 16:12:23 | 0.10 | 960,000 | 960.00 | O |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: +44 (0) 203 8794 460 | support@advfn.com |
ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
ADVFN France ADVFN US ADVFN Korea |